Hilig, Robejane C.
HRN: 27-57-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2025
CEFUROXIME 500MG (TAB)
08/01/2025
08/08/2025
PO
500mg
BID
NSVD With RMLE
Checking Initial Appropriateness